Article Text

Download PDFPDF
CASE REPORT
Isolated limb infusion as a treatment option for malignant granular cell tumour
  1. Ye Tian1,
  2. Edward Fox2,
  3. Joseph Drabick3,
  4. Colette Pameijer4
  1. 1Penn State College of Medicine, Hershey, Pennsylvania, USA
  2. 2Orthopedic Surgery, Penn State College of Medicine, Hershey, Pennsylvania, USA
  3. 3Hematology Oncology, Penn State College of Medicine, Hershey, Pennsylvania, USA
  4. 4Surgery, Penn State College of Medicine, Hershey, Pennsylvania, USA
  1. Correspondence to Dr Colette Pameijer, cpameijer{at}pennstatehealth.psu.edu

Summary

A 54-year-old man presented with a painful lesion on the right posterior calf with MRI identifying a 5 cm lesion in the medial head of the gastrocnemius. He underwent wide local excision of the tumour, and the final pathology was consistent with atypical granular cell tumour. Three years later, he developed a recurrent right popliteal mass. Complete staging workup also identified multiple lung nodules and a caecal polyp that were consistent with metastatic granular cell tumour. He was started on pazopanib and deemed a poor candidate for palliative resection due to encasement of the popliteal vessels. The patient refused above-the-knee amputation (AKA) at that point and was evaluated for isolated limb infusion as an alternative. He received three cycles of isolated limb infusion within a 2-year period and achieved good response from the first two cycles. He underwent AKA 4 years after his diagnosis of malignant granular cell tumours and is currently doing well.

  • chemotherapy
  • surgical oncology

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors YT was involved in writing the manuscript and collecting the data. EF and JD provided patient care and edited the manuscript, CP conceived the case report, assisted YT in writing the manuscript and with submission.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.